A quivering or irregular heartbeat (arrhytmia) that can lead to blood clots, stroke, heart failure and other heart-related complications
More than 46.1 million people affected worldwide –2/3 are not addressed by standard of care (1)
About 1 millions procedures per year worldwide growing rapidly over 11%
CAGR 2010-2018 (2)
1.2 million new cases are diagnosed annually in the U. S. alone (3)
Approximately 9% of people over 65 suffer from atrial fibrillation (4)
Chung SS, Havmoeller R, Narayanan K, et al.: Worldwide Epidemology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014 Feb25:129(8):837-47
St. Jude Medical Analyst and Investor Presentation ,Page 58, Feb 5, 2016
Articure Investor Presentation, Page 3, March 2018
Center for Disease Control and Prevention - Atrial Fibrillation Fact Sheet
Electrical isolation of the four pulmonary veins in the left atrium is the cornerstone of AF treatment. Physicians use ablation catheters to create lesions around the pulmonary veins to block electrical triggers.
Close to 40% of patients will required 2nd procedure over time due to key technological limitations of existing approved products.
Poor / No
No lesion monitoring lesions
NO-CONTACT GUIDED ABLATION
No Lesion Gaps
Shimon Eckhouse, PhD
A leading medical entrepreneur, founded more than 20 companies including Syneron Ltd. Lumenis Ltd & Ventor.
Co-invetor of propietary Elos & IPL technologies - cornerstone for many aesthetic medical devices. Has over 25 registered patent & 50 published paper in lesding referance journals and confernces.
Dr Eckhouse holds Ph.D. in Pysics from university of California.
15 years of R&D experience. Highly skilled in medical devices project management and electro-mechanical delivery systems integrations.
Past project management positions with St. Jude Medical (2007-2015) leading technologies through regulatory approvals.
M.Sc. In Biomedical Engineering from the Grove school of Engineering, New York (2005)
Yuri Megel, PhD
Physicist with over 25 years experience of hardware and software embedded ultrasound systems, micro transducers development & piezo ceramic sensors
Hands-on expertise in physiological signal processing, front-end & data acquisition boards, data analysis and algorithms development.
M.Sc in Engineering & Ph.D in Geophysics from the Donetsk Polytechnic Institute, Ukraine (1981)
More then15 years of experience of high power ultrasound technology to a wide range of medical uses.
Previously CTO of Cardiosonic, ultrasonic ablation catheter for hypertension treatment. Currently founder & CTO of Archimedus, medical ultrasound esthetic company.
M.Sc. In Biomedical Engineering from the Technion Institute, Israel (2000). Serves as technological consultant of the company